Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca's fixed-dose triple-combination therapy BREZTRI AEROSPHERE ...

Chicago's skyline has been shrouded in mystery as conflicting reports of toxic air chemicals swirl, leaving residents ...

A concerning air quality mystery has broken out, as the city was reportedly blanketed with toxic chemicals - although not ...

Murder charges have been dropped against five individuals originally arrested and charged in connection to the death of ...

New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...

In children and adults with established asthma, viral upper respiratory tract infections play a key role in producing acute exacerbations that may lead to healthcare utilization. Both ...

Adults diagnosed with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a significantly ...

Even in acute asthma, there may be no audible wheeze if someone ... given the approach has been shown to reduce severe exacerbations in both adults and children. A recent Asthma and Lung commissioned ...

Treatment with amlitelimab led to nominally significant and clinically meaningful reductions in asthma exacerbations at ... bronchitis, acute sinusitis and headache. All were mild-to-moderate ...

Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults with moderate ... and clinically meaningful ...

Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults ... reductions in asthma exacerbations at the ...